Prudential Financial’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.57M | Buy |
|
|||||
|
2023
Q2 | $1.25M | Buy |
|
|||||
|
2023
Q1 | $1.46M | Sell |
|
|||||
|
2022
Q4 | $1.98M | Buy |
|
|||||
|
2022
Q3 | $1.73M | Sell |
|
|||||
|
2022
Q2 | $3.16M | Sell |
|
|||||
|
2022
Q1 | $5.9M | Sell |
|
|||||
|
2021
Q4 | $6.91M | Sell |
|
|||||
|
2021
Q3 | $10.5M | Buy |
|
|||||
|
2021
Q2 | $7.59M | Sell |
|
|||||
|
2021
Q1 | $8.84M | Sell |
|
|||||
|
2020
Q4 | $11M | Buy |
|
|||||
|
2020
Q3 | $9.4M | Buy |
|
|||||
|
2020
Q2 | $10.2M | Buy |
|
|||||
|
2020
Q1 | $5.4M | Sell |
|
|||||
|
2019
Q4 | $7.19M | Buy |
|
|||||
|
2019
Q3 | $5.08M | Buy |
|
|||||
|
2019
Q2 | $3.26M | Buy |
|
|||||
|
2019
Q1 | $2.76M | Buy |
|
|||||
|
2018
Q4 | $1.33M | Buy |
|
|||||
|
2018
Q3 | $1.75M | Buy |
|
|||||
|
2018
Q2 | $1.28M | Sell |
|
|||||
|
2018
Q1 | $10.3M | Sell |
|
|||||
|
2017
Q4 | $21.5M | Buy |
|
|||||
|
2017
Q3 | $13.2M | Buy |
|
|||||
|
2017
Q2 | $1.93M | Sell |
|
|||||
|
2017
Q1 | $2.1M | Buy |
|
|||||
|
2016
Q4 | $1.26M | Buy |
|
|||||
|
2016
Q3 | $1.02M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $2.83M | Buy |
|